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University of Manchester, Manchester, UKABSTRACT The ability to control the morphologies of biomolecular aggregates is a central objective in the study of self-assem-
bly processes. The development of predictive models offers the surest route for gaining such control. Under the right conditions,
proteins will self-assemble into fibers that may rearrange themselves even further to form diverse structures, including the for-
mation of closed loops. In this study, chicken egg white ovalbumin is used as a model for the study of fibril loops. By monitoring
the kinetics of self-assembly, we demonstrate that loop formation is a consequence of end-to-end association between protein
fibrils. A model of fibril formation kinetics, including end-joining, is developed and solved, showing that end-joining has a distinct
effect on the growth of fibrillar mass density (which can be measured experimentally), establishing a link between self-assembly
kinetics and the underlying growth mechanism. These results will enable experimentalists to infer fibrillar morphologies from an
appropriate analysis of self-assembly kinetic data.INTRODUCTIONThe self-assembly of polypeptides into fibrillar aggregates
is relevant into areas as diverse as disease pathology (1)
and the synthesis of biocompatible nanomaterials (2,3).
The formation of amyloid-like fibrils, which are rich in
b-sheet structure, has been the focus of much research
due to the universal nature of the self-assembly process:
most if not all proteins can form amyloid-like fibrils under
appropriate (not necessarily physiological) environmental
conditions (4). The kinetics of amyloid fibril formation
can be tracked using b-sheet-binding dyes such as Congo
Red or Thioflavin T (Th T) or monitoring turbidity, while
the morphology of the resulting fibrils can be assessed
using electron microscopy. However, these are usually
measured in separate studies—few attempts have been
made to link self-assembly kinetics to fibril morphology.
Establishing such a link would be an important step for-
ward in understanding, predicting, and controlling protein
aggregation processes.
The kinetics of amyloid-like fibril formation, as
measured using spectroscopic assays such as the thio-
flavin T fluorescence assay (5–7), are typically character-
ized by growth curves of a sigmoidal or sigmoidal-like
form, in which a quiescent lag phase—often lasting
hours or even days—is followed by rapid growth, culmi-Submitted October 7, 2014, and accepted for publication March 12, 2015.
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0006-3495/15/05/2300/12 $2.00nating in a plateau when monomeric protein is exhausted
or the system reaches equilibrium. The lag phase can be
abolished by adding preformed fibril seeds, suggest-
ing that a nucleation process plays a key role. Indeed,
theoretical models that include nucleation, growth by
monomer addition at fibril ends, and autocatalysis via
fibril fragmentation, can successfully reproduce these sig-
moidlike growth curves (8–10). Here the role of fibril
fragmentation is to form new growth-competent fibril
ends that accelerate the depletion of monomer during the
growth phase, leading to the characteristic sigmoidal
form for the fibril growth curve. These models also
predict characteristic scaling laws for the lag time and
maximal growth rate as functions of the protein concentra-
tion. An alternative protein aggregation process may
exhibit rapid fibril growth from the very onset, with an
absence of lag phase—examples of this phenomenon are
cited below.
Amyloid fibrils have been observed to form in a wide
variety of morphologies, including long rigid fibrils, short
rodlike forms, tapes, twisted ribbons, nanotubes, and
flexible wormlike chains that are characterized by a short
persistence length (1,11–17). Fibril polymorphism may
become manifest when the self-assembly takes place under
different conditions, as seen for b2-microglobulin (18), or,
alternatively, two forms may arise simultaneously, as
observed for amyloid b (19,20). Intriguingly, a number of
systems that form fibers with wormlike chains have also
been observed to form ring or loop structures (e.g., apoli-
poprotein C-II (21), a-synuclein (22), the crystallinshttp://dx.doi.org/10.1016/j.bpj.2015.03.021
Kinetic of Ovalbumin Fibril Formation 2301(23,24), human serum albumin (25), b-lactoglobulin (26),
and aS2-casein (27)). The simplest hypothesis for the for-
mation of loops by protein fibrils is the joining of their
two ends (28). This hypothesis implies a link to fibril
growth kinetics, because end-joining decreases the number
of fibril ends available for growth by monomer addition. In
this study, we show that such a link between end-joining
and self-assembly kinetics indeed exists, using the
44.5-kDa glycoprotein OVA, the main protein component
of avian egg white, as a model system. Due to its abun-
dance, OVA is a convenient model system for the study
of fibril formation. Under acidic or near-neutral conditions
(pH % 7) and elevated temperatures, OVA forms fibrils
that display amyloid-like behavior in that they bind the
dyes Th T and Congo Red (29–33) (Fig. 3 and Figs. S1
and S2 in the Supporting Material). The formation of
amyloid-like fibrils is more pronounced when the reaction
takes place in a reducing environment (34). Published im-
ages of OVA fibers indicate flexible morphologies (32), but
under reducing conditions, more rigid fibers have also been
observed (34). We investigate in detail the self-assembly
kinetics of OVA fibrils, under conditions where flexible
fibrils, with some closed loops, are formed. We develop a
theoretical model that includes both fibril fragmentation
and the joining of fibril ends. By fitting our model to our
experimental data, we show that both fragmentation and
end-joining play important roles in the self-assembly
kinetics.MATERIALS AND METHODS
Preparation of ovalbumin fibrils
Ovalbumin (isolated from chicken egg white) was used in this study (Grade
5, A5503; Sigma, St. Louis, MO). To produce reduced OVA samples, the
lyophilized protein powder was dissolved in aqueous 10 mM ammonium
acetate, 10 mM DTT (dithiothreitol) buffer (pH 6.8), achieving the desired
protein concentrations (ranging between 0.1 and 12.8 mg/mL). Subse-
quently, the sample, distributed in 1.2 mL aliquots in Eppendorf tubes
secured with parafilm, was incubated on a benchtop block heater at 37C
for 2 h. Reduced protein aliquots were mixed, cooled on ice, and filtered
with a 200-nm cutoff filter. Fibrils were produced by incubating the samples
at 60C. Incubation typically occurred in 96-well plates in the plate reader
or on the block heater (in the latter case, Eppendorf tubes were secured with
parafilm).Thioflavin T fluorescence kinetics at 60C
Fibril formation kinetics were followed by means of the Th T fluorescence
assay. Th T was added to reduced protein samples to a concentration of
55 mM. Aliquots of 100 mL were added in 96-well plates. Nonbinding
surface plates (coated with a PEG-like polymer; Corning Incorporated,
Corning, NY) and Nunc-Immuno StarWell Modules (PolySorp surface,
polystyrene coating; Nunc Products, Thermo Fisher Scientific, Guilford,
CT), the latter sealed with polyethylene caps, were used for these exper-
iments. Both plate types were sealed additionally with a transparent
adhesive Greiner plate sealer and secured further with parafilm to
minimize solvent evaporation. Typically 60 out of a total of 96 wellscontained the protein solution with the remaining 36 being used for
blanks. The kinetics were measured using a Synergy 2 plate reader
(BioTek, Winooski, VT). The microplate was kept at a temperature of
60C for plate-reader measurements. Th T fluorescence readings (lexc ¼
440 nm, lem ¼ 485 nm) were collected every 8 min, with an 18-Hz
shaking frequency (at medium setting). Th T binding kinetics were probed
for 3–5 days.Temperature-dependence of Th T binding kinetics
The kinetics of Th T binding were measured on quiescent samples on
a Cary Eclipse fluorimeter, fitted with a Peltier device (Varian, Cary,
NC). A 3.0 mL quantity of 6.0 mg/mL reduced protein solution
(prepared as described above) was added to 10-mm-path quartz cuvettes
(Starna Scientific, Hainault, Essex, UK). The kinetics were monitored
for 24 h, collecting a reading every 10 min. OVA Th T binding kinetics
were measured at 50, 55, 60, 65, 70, and 80C in this fashion. These ex-
periments were repeated in triplicate, with buffer blanks being measured
in duplicate.Transmission electron microscopy
For transmission electron microscopy (TEM), 2.0 mL of a reduced OVA
fibril suspension was deposited on formvar/carbon-coated TEM grids
(TAAB Laboratories Equipment, Aldermaston, Berkshire, UK). The sam-
ple was allowed to equilibrate for 5 min, after which the excess was
removed with a filter paper wedge and washed with 20 mL of distilled
H2O, which was then immediately removed. The samples were stained
with 1% w/v uranyl acetate. Staining time ranged between 30 and 45 s.
Excess stain was removed and the grids were allowed to dry for at least
20 min before analysis.
TEM images were collected on a CM 120 Philips BioTwin transmis-
sion electron microscope operating at an accelerating voltage of 80 kV
(FEI, Hillsboro, OR). Images were captured by an Orius 1000 charge-
coupled device camera (Gatan, Pleasanton, CA) controlled using
DIGITALMICROGRAPH (Gatan) imaging software. Image analysis was
carried out using the IMAGEJ program (National Institutes of Health,
Bethesda, MD).Protein quantitation
Whenever necessary, protein concentrations were determined using the
Bradford assay. A quantity of 10 mL of standard protein solution or fibril
sample (appropriately diluted—1, 2, 5, or 10—in 10 mM NH4CH3COO
10 mM DTT buffer) was dissolved in 200 mL of Bradford reagent. The
absorbance was recorded at 450 and 595 nm and the ratio of the two read-
ings was used to construct the standard curve and to determine the concen-
trations. OVA was used as the protein standard, allowing accurate
concentration determination.Model for fibril formation by linear growth,
end-joining, and fragmentation
Our kinetic and morphological observations, presented in Results and Dis-
cussion, suggest that OVA fibril formation involves seeded linear fibril
growth, combined with a secondary process, such as end-to-end joining,
that can produce loops. Indeed, a kinetic model that includes seeded linear
growth and end-joining (which can be solved analytically; see the Sup-
porting Material) does predict rapid fibril growth followed by saturation,
similar to what we see in our experiments. However, this model does
not reproduce the slower growth regime we observe that follows the rapid
growth regime. When fragmentation is included, three growth phasesBiophysical Journal 108(9) 2300–2311
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which eventually reaches a steady state (Fig. S10). In the absence of frag-
mentation, the rapid initial growth is followed by transition to the steady
state, and the slower growth regime is absent (Fig. S10). We find the
experimental data is best fit to a model that includes fibril fragmenta-
tion—i.e., the generation of new fibril ends by breakage of growing fibrils
(see Figs. 3 and 6). This suggests that fragmentation is a significant factor
in the self-assembly of OVA, even though its growth kinetics display none
of the characteristics typically associated with fragmentation-based
models.
A model for the self-assembly of fibrils that incorporates end-joining
and loop formation can be summarized using the following reaction set,
schematically presented in Fig. 1:
Fi þ m!kþ Fiþ1; (1)
kfFi#
kj
Fij þ Fj;
i; jRnc;
(2)
loop
kfFi #
kl
Fi: (3)FIGURE 1 Schematic representation of processes described by Eqs. 1–3.
These processes are thought to take place during OVA self-assembly. The
process giving rise to the initial seed population is not defined explicitly
and instead is modeled by the presence of a seed population that forms
rapidly at early times. We suggest, however, that for ovalbumin, seeding
occurs at interfaces (e.g., the air/water interface and/or the walls of the
container) represented schematically (hashed bars). (Red square) Monomer
protein units; (blue and pink ovals) active nuclei and fibrillar units.
Three processes are active during fibril formation: elongation, fragmenta-
tion, and end-joining. Two consequences of end-joining are illustrated:
fibril concatenation and loop-formation. To see this figure in color,
go online.
Biophysical Journal 108(9) 2300–2311Here, Fi is a single fibril of length i, m is a single monomer, nc is the number
of monomers in the smallest stable fibril (fibrils shorter than nc are assumed
to dissolve into monomers), and Fi
loop is a loop of size i. The total monomer
concentration is denoted with m(t). The first reaction describes the elonga-
tion of a fibril by addition of a monomer to either of its ends, with rate con-
stant kþ. The second reaction describes the breakage of a fibril of length i at
any point between two of its monomers with rate constant kf; the opposite
process of joining two fibril ends has rate constant kj. The third reaction
describes the breakage of a loop of length i in a similar way to that of a
single fibril (note: a loop contains one more breakable bond than a fibril
of the same length) with the same rate constant kf; similarly, in the opposite
process a loop is formed with rate constant kl; this rate is given by kj/V
(where V is volume) multiplied by the probability Ploop of two ends of a
wormlike chain coming together (21). In our study, to a first approximation,
we take kj and kl to be of the same magnitude and it should be noted that kj
and kþ are an intrinsic property of any given fibril-forming system and may
depend on the structural characteristics of the aggregating protein.
The rate equations for the mass densityM(t) and the number density N(t)
of fibrils may be written as
dM
dt
¼ 2kþðmtot MÞN  kf ncðnc  1ÞN;
Mð0Þ ¼ M0;
(4)
dN 2
dt
¼ kf ½M  ð2nc  1ÞN  kjN ;
Nð0Þ ¼ N0;
(5)
where mtot represents the total density of protein monomers, and N0 andM0
are the initial (seed) fibril number density and the fibril mass concentration,
respectively. Equations 4 and 5 were derived from the master equation for
the number density of fibrils of sizes iR nc, where, to the first approxima-
tion, we ignored the contributions to M and N from loops (see the Support-
ing Material).
Solving for the steady state of the set of Eqs. 4 and 5 provides an expres-
sion for the fibril mass concentration M* and number density N*, in the
long-time limit:
M ¼ mtot  kf ncðnc  1Þ
2kþ
; (6)
N ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
k2f ð2nc  1Þ2 þ 4kjkfM
q
 kf ð2nc  1Þ
2kj
: (7)
The dynamical trajectories leading to the state (M*, N*) provide predictions
for the self-assembly kinetics. These trajectories can be obtained analyti-
cally in an approximate form (assuming small kf and sufficiently large
N0), or using numerical simulations, both of which are described in the
following sections. A summary of the solutions to the fibrillar growth ki-
netic model involving end-to-end joining under different initial conditions
is provided in Table 1.Analytical solution for the self-assembly kinetics
of a model including monomer addition,
fragmentation, and end-joining
An approximate solution for the system of Eqs. 4 and 5 can be obtained in
closed form using the following method, for the choice of parameters for
TABLE 1 Summary of solutions to fibrillar growth kinetic models involving end-to-end joining
Model Solution Comments
dM=dt ¼ 2kþðmtot MÞN
dN=dt ¼ kjN2
MðtÞ ¼ mtot  mtot M0ð1þ kjN0tÞ2kþ=kj
exact solution for the
fibrillar mass density M(t)
Eq. 18 exact implicit solution N(M), valid
for any combination of parameters
dN=dt ¼ kf M  kjN2
dM=dt ¼ 2kþðmtot MÞN
MðtÞ ¼ mtot  mtot M0
1 M0
mtot
þ M0
mtot
coshð2kþNtÞ þ N0
N
sinhð2kþNtÞ
exact solution for M(t),
valid when kj ¼ 2kþ
Eq. 16 approximate solution for M(t), valid when
the kinetics are reminiscent of decay profiles,
lacking a measurable lag phase
M is the concentration of monomer incorporated in fibrils (fibril mass density) at any time; N is the concentration of fibrils (number density);M0 is the initial
fibril mass density; N0 is the initial number density of fibrils; mtot is the total monomer density; N
z
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
kf mtot=kj
p
is the equilibrium number density of fibrils;
kþ is the linear growth rate constant; kj is the end-joining rate constant; and kf is the fibril fragmentation rate constant.
Kinetic of Ovalbumin Fibril Formation 2303which m(t) does not develop a sigmoidal shape; a closed form solution for
the case where m(t) develops a sigmoidal shape has been obtained very
recently in Michaels and Knowles (35).
First, it is useful to define m ¼M/M* and n ¼ N/N*, so that the equation
is now expressed in terms of the dimensionless ratio of fibril mass and num-
ber density relative to their steady-state values. After rescaling the time var-
iable t ¼ 2kþN*t, and assuming kf << kþmtot and kf << kjmtot, the system
from Eqs. 4 and 5 can be written as
dm
dt
¼ ð1 mÞn;
mð0Þ ¼ M0=M ¼ m0;
(8)c ¼
Y2r1

2r
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 m0
p  Y2rþ12r ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1 m0p þ 2n0ﬃﬃﬃﬃﬃﬃﬃﬃ1m0p Y2r2r ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1 m0p 
J2r1

2r
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 m0
p  J2rþ12r ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1 m0p þ 2n0ﬃﬃﬃﬃﬃﬃﬃﬃ1m0p J2r2r ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1 m0p  ; (15)dn 2
dt
¼ rn þ rm;
nð0Þ ¼ N0=N ¼ n0;
(9)
where rh kj/(2kþ) is the ratio of the end-joining to the elongation rate con-
stants. Equation 8 can be integrated yielding an expression form(t) given an
expression for n(t) of
mðtÞ ¼ 1 ð1 m0Þe
R t
0
dt0nðt0Þ
: (10)
At late times n z 1, yielding
mðtjn/1Þ ¼ 1 ð1 m0Þet; (11)
m(tjn/ 1) is a monotonically increasing, concave function and thus may
serve as a good approximation to m(t) at early times, provided m(t) does
not develop a sigmoidal shape. Using this expression as an approximation
for m(t) at early times, we obtain the following nonlinear first-order ordi-
nary differential equation for n(t):dn
dt
¼ rn2 þ r  rð1 m0Þet;
nð0Þ ¼ n0:
(12)
This equation can be solved (see the Supporting Material for details) asnðtÞ ¼ u
4r
c½J2rþ1ðuÞ  J2r1ðuÞ þ Y2rþ1ðuÞ  Y2r1ðuÞ
cJ2rðuÞ þ Y2rðuÞ ;
(13)
u ¼ 2r
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 m0
p
et=2; (14)with Ja(x) and Ya(x) being Bessel functions of the first and second kind,
respectively. Equation 13 can be integrated and combined with Eq. 10 to
obtain the approximation for m(t),
mðtÞ ¼ 1 ð1 m0Þ

 
cJ2r

2r
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 m0
p þ Y2r2r ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1 m0p 
cJ2r

2r
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 m0
p
et=2
þ Y2r2r ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1 m0p et=2
!1=r
;
(16)
where the constant c is as defined in Eq. 15. Plots of the approximate
solution given by Eqs. 13 and 16 are shown in Fig. S9 along with
curves generated numerically; clearly, the agreement between them is
excellent.
An expression relating m and n may also be derived from Eqs. 8 and 9:
n
dn
dm
¼  r
1 mn
2 þ rm
1 m: (17)
This is solvable for any n0, r, and m:Biophysical Journal 108(9) 2300–2311
nðmÞ ¼
8>>>><
>>>>:
"
n20 
2rm0  1
2r  1

1 m
1 m0
2r
þ 2rm 1
2r  1
#1=2
; rs1=2;

n20  1
 1 m
1 m0 þ ð1 mÞln
1 m
1 m0 þ 1
	1=2
; r ¼ 1=2:
(18)
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mass densities.Simulation of the self-assembly process
including end-joining
Kinetic (stochastic) Monte Carlo simulations were performed by imple-
menting a Gillespie algorithm using FORTRAN 95 and then by averaging
over 150 replicate simulations for each set of conditions. The number of
loops and fibrils were tracked for each length, along with the total monomer
population m(t). Length distributions were obtained at points in the simula-
tion where the total fibril mass had reached a specific threshold (i.e., instead
of at particular points in time).FIGURE 2 TEM images of fibrils formed by OVA. (A) Entangled and
branched fibrils formed by 0.4 mg/mL OVA heated at 60C. (Inset)
Example of a branched fibril. (B) Entangled and branched fibrils formed
by 12.8 mg/mL OVA heated at 60C. (C) Loops formed by 0.4 mg/mL
OVA fibrils at 60C. (D) Loops formed by 6.4 mg/mL OVA fibrils at
80C. (E) Experimental length distributions of OVA (6.4 mg/mL, incubated
at 80C) loops. For additional TEM images of loops and branches, see Figs.
S4 and S5.RESULTS AND DISCUSSION
Heat treatment of reduced OVA produces fibrillar
aggregates and closed loops with amyloidlike
Congo Red and Thioflavin T binding properties
Incubation of reduced (10 mM DTT) OVA for several
hours at 60C at near-neutral pH (10 mM ammonium ace-
tate, pH 6.8) produced species that bound Congo Red (see
Fig. S1) and Th T. Examination of the heated OVA samples
by TEM revealed the presence of fibrillar aggregates
(Fig. 2, A–C). The fibrils formed by reduced OVA under
these conditions are flexible with a persistence length of
~26 nm (see Fig. S2). The fibrils often appeared to be en-
tangled, particularly at higher protein concentrations, a
feature that prevents an accurate determination of their
length distribution. Interestingly, our TEM images often
reveal the formation of loops, in which the two ends of a
single fibril appear to be annealed. Loops were observed
in TEM images of heat-treated samples at both low
(0.4 mg/mL) and high (6.4 and 12.8 mg/mL) initial con-
centration of protein (Fig. 2, A–D). The presence of loops
in the samples provides clear evidence that fibrils of length
greater than the persistence length can join end-to-end.
Analysis of images from samples in which loop formation
was abundant (80C, 6.4 mg/mL) showed that the length
distribution of fibrils in loops is centered at 120 nm, but
skewed toward longer loops (loops as large as 360 nm in
circumference could be seen; see histogram in Fig. 2 E).
No loops were seen with circumference smaller than twice
the persistence length, the smallest measured loop having a
length of 74 nm.Biophysical Journal 108(9) 2300–2311The kinetics of OVA self-assembly
The self-assembly kinetics of reduced OVA differ strongly
from the standard sigmoidal behavior, and can be divided
into three regimes (Fig. 3 A). In our experiments, fibril
mass, as measured by the Th T fluorescence, increases
sharply from the start of the experiment, with no apparent
FIGURE 3 OVA self-assembly kinetics moni-
tored by thioflavin T binding. (A) Kinetic traces
of Th T binding by OVA between 0.4 and
12.8 mg/mL. (Symbols) Experimental data; (red
solid lines) fitted curves according to Eq. 16. (B)
Log-log plot of the initial growth rate versus con-
centration (red line represents a linear scaling rela-
tion). (C) Concentration dependence of the ratio
of end-joining and growth rate constants. Interest-
ingly, this factor decreases with concentration,
possibly reflecting the lower diffusivity of the
initial seed population in concentrated mixtures
(which may arise because the effect of fibril length
on growth is not taken into account by the model).
(D) Concentration dependence of the timescaling
factor 2kþN*. While this factor increases with con-
centration, the observed dependence is much
weaker than the one predicted from the theory
(Eq. 7). (E) Concentration dependence of the ratio
N0/N*. Because N* is only weakly dependent on
concentration, a constant ratio of N0/N*z 0.5 pre-
dicts that N0 is concentration-independent, a neces-
sary condition for the model to be consistent with
the linear concentration scaling of the initial rate
(B). To see this figure in color, go online.
Kinetic of Ovalbumin Fibril Formation 2305lag phase (although at very early times, our measurements
are obscured by a transient behavior that we attribute to tem-
perature fluctuations). This initial growth phase is followed
by a second growth regime, where the Th T fluorescence
continues to increase but considerably more slowly, after
which, the Th T fluorescence reaches a plateau.
The absence of a lag phase suggests that fibril formation
in our experiments does not proceed via a classic homo-
geneous nucleation and growth mechanism by monomer
addition. This interpretation is supported further by mea-
surements of the relationship between protein concentration
and the initial growth rate (Fig. 3 B). For a mechanism
involving homogeneous nucleation and growth, one would
expect that the initial aggregation rate, in the absence of
seeds, to be equal to the initial nucleation rate, which can
be assumed to scale as [protein concentration]nc (for rate-
limited reactions), nc R 2 being the size of the nucleus.
However, as shown in Fig. 3 B, in our experiments the
initial aggregation rate scales linearly with protein concen-
tration, suggesting that a process other than homogeneous
nucleation must give rise to the initial population of
growth-competent species. We also noticed that the initial
aggregation rate was influenced by the material of the vessel
in which our experiments were performed, with aggregation
in microplates coated with a PEG-like polymer occurring
substantially faster than in uncoated plates (see the Support-
ing Material for details). The initial aggregation rate also
depends on the volume of the sample, with samples with a
smaller surface area to volume ratio exhibiting less growth
(see Fig. S6, D and E). These findings suggest that fibril
growth is seeded at the walls of the sample container. For
seeded growth, the initial growth rate is controlled by the
initial monomer addition rate, which scales linearly withnumber of seeds and protein concentration. If the surface
is saturated with fibril seeds, then the number of seeds is
independent of protein concentration, which would give
rise to the observed linear scaling of the initial rate with
protein concentration.Theoretical analysis of the model for fibril
formation by linear growth, end-joining,
and fragmentation
Results for the theoretical trajectories of the model
described by Eqs. 8 and 9 reveal qualitatively different types
of dynamical behavior, depending on the parameters—in
particular on the initial concentration of seed fibrils N0
(see the phase diagram shown in Fig. 4 A).
For small seed density N0 << N* (i.e., if the initial con-
centration of seeds is much smaller than the long-time fibril
density), the model predicts sigmoidal kinetics for the fibril
massM. In this case, the only apparent effect of end-joining
is to smooth out the transition between the rapid growth
phase and the plateau (Fig. 4, B and C, n0 ¼ 0.001). By tak-
ing the kinetics of the fibril number density N(t) into ac-
count, we may distinguish two cases: if the end-joining
rate constant is much less than the elongation rate constant,
i.e., kj << 2kþ, N(t) increases slowly as the bulk of the free
protein aggregates, increasing sharply to its long-time value
during the late stages of the process (Fig. 4 C, r ¼ 0.1).
When kj is comparable to or greater than 2kþ, N(t) follows
a sigmoidal form similar to M(t) (Fig. 4 C, r ¼ 2).
Contrasting behavior is predicted by the model if the
initial seed concentration is sufficiently high. In this case,
the model predicts rapid fibril growth from the start, with
no lag phase (Fig. 4 B, n0 ¼ 1.5). For a small end-joiningBiophysical Journal 108(9) 2300–2311
FIGURE 4 Theoretical trajectories of the model described by Eqs. 8 and
9. (A) Phase diagram of the system showing four distinct types of dynamics:
(solid line) small initial seed population and small end-joining rate (n0 ¼
0.001, r ¼ 0.1); (dotted line) small initial seed population and end-joining
rate comparable to elongation (n0¼ 0.001, r¼ 2); (dashed line) high initial
seed population and low end-joining rate (n0 ¼ 0.001, r ¼ 0.1); and (dot-
dashed line) high end-joining rate and high initial seed population (n0 ¼
1.5, r ¼ 2). The dynamics of the normalized fibril mass density m and
the normalized fibril number density n for these four cases are shown in
panels (B) and (C), respectively. When the end-joining rate constant is com-
parable to the elongation rate constant and the initial seed concentration is
also high, fibril growth sites are depleted at early times due to end-joining of
fibril ends before they begin increasing again at later times as a result of
fibril breaking; this fluctuation generates a characteristically delayed equil-
ibration of the fibrillar mass fraction growth curve.
2306 Kalapothakis et al.rate kj << 2kþ,M(t) shows a single growth phase, ending in
a plateau, while N(t) decays monotonically to its long-time
value N* (Fig. 4, B and C, r¼ 0.1). Interestingly however, if
the end-joining rate constant is significant (kj x 2kþ), the
model predicts two distinct fibril growth phases: the fibril
mass concentration M(t) initially grows rapidly, followed
by a slower growth phase, before it eventually reaches a
plateau. This behavior is correlated with the kinetics of
the fibril number N(t), which is nonmonotonic: N(t) de-
creases during the initial growth phase, overshoots its
long-time value N*, and gradually increases toward N* dur-
ing the second fibril growth phase (Fig. 4 C, r ¼ 2).Biophysical Journal 108(9) 2300–2311The biphasic aggregation kinetics predicted by the model
is strikingly similar to our experimental observations for
OVA. Therefore, the model leads us to suggest not only
that both fragmentation and end-joining are important for
OVA, but also that in our experiments self-assembly starts
with a large number of short but growth-competent species,
which due to their small size may still represent a very small
proportion of the total mass fraction. The model also pre-
dicts that the absolute number of fibrils in our experiments
(as opposed to the fibril mass) actually decreases in time
from its initially high value, before again increasing.
Thus our theoretical analysis suggests that the kinetics
observed in our experiments reflect the interplay between
the two competing processes of fragmentation (which cre-
ates new growth-competent ends) and end-joining (which
decreases the number of fibril ends). Initially, growth pro-
ceeds rapidly from a seed population that consists of
numerous small species. Later, a relatively high rate of
end-joining depletes the number of fibril ends to which
free monomers may attach: this process is manifested by
the decrease in the growth rate that is evident in the second
observed growth phase. Finally, a small fibril breakage rate
eventually ensures there are enough ends for the remaining
free monomers to attach to, bringing the fibril growth pro-
cess to completion.Experimental confirmation of the growth pathway
Fitting our experimental Th T fluorescence curves for oval-
bumin (Fig. 3) using our analytical formula (Eq. 16) for the
self-assembly kinetics including end-joining and fragmenta-
tion allows us to estimate the relevant kinetic parameters
(Fig. 3, C–E). The initial number density of fibril seeds
(i.e., growth-competent species) is indeed estimated to be
high (N0/N* z 0.5, Fig. 3 E), but these seeds nonetheless
represent only a very small proportion of the total amount
of protein present (M0 << mtot). Interestingly, the rate
constants for elongation and end-joining are of similar
magnitude (Fig. 3 C), suggesting that end-joining is of
comparable importance to the kinetics. As can be seen in
Fig. 3 D, the timescale factor 2kþN* increases with con-
centration, but the observed dependence is weaker than
predicted from the theory (Eq. 7). This, together with the
observation that the ratio N0/N* is a constant (Fig. 3 E),
implies that N0 is concentration-independent and is consis-
tent with our previous argument that fibril seeds are satu-
rated at surfaces.
Having all the relevant parameters in hand, we can
perform a simulation of the model using the parameters
derived from fitting of the experimental data, which allows
us to monitor evolution of a species over time. Due to the
high number of fibrils forming early during polymerization,
we observe loops forming rapidly during the early stages
(Fig. 5 A), and then increasing at a diminishing rate. This
gives rise to a loop length distribution that increases fairly
FIGURE 5 The dynamics for the loop number
fraction generated by stochastic simulations for
(A) heavily seeded growth and (B) for a case exhib-
iting sigmoidal kinetics. We find that the number of
loops is established early in the kinetics for highly
seeded growth. This is in contrast to low initial
seed concentrations where the appearance of loops
does not happen until further into the growth ki-
netics and does not reach an appreciable number
until late times. (C) Simulated loop perimeter dis-
tribution at the midpoint; (D) simulated loop
perimeter distribution at the end-point. Both simu-
lated distributions are normalized to the average
fibril length at equilibrium. Note that N*/M* scales
as the inverse mean fibril length. Therefore, the
simulation loop length is scaled by the mean sta-
tionary fibril length and gives an indication of
how long the loops are relative to this mean value.
To see this figure in color, go online.
Kinetic of Ovalbumin Fibril Formation 2307sharply at lengths >2lp and then decays more slowly with
increasing loop length (Fig. 5, C and D). The length distri-
bution for loops is thus qualitatively similar to the one
observed experimentally, i.e., peaked but with a long tail
(Fig. 2 E). This loop perimeter distribution is established
early (when <50% of the starting material has aggregated)
and does not change significantly over time. Therefore, it
may be expected that in systems with flexible fibrils with
sufficiently high initial seeding species the loop population
will have formed after the initial growth phase and remain
intact until the process is completed. This situation can
be contrasted with the curves displaying sigmoidal kinetics
(resulting from small initial seed concentrations) where
loops only appear after some lag-time and only reach an
appreciable number when the self-assembly process is
almost complete (Fig. 5 B). The model studied in this article
therefore provides a framework for predicting when
different fibril morphologies arise.
It is also worth commenting on the observation that OVA
fibrils exhibit branched morphologies (Fig. 2 A inset; see
also Fig. S5). We can show that these branches do not
form by fibrils overlapping on the surface of the TEM
grid as an artifact of the deposition process, by analyzing
the angular distribution of the fibril branches (Fig. S7).
Such branching may occur via two different mechanisms:
heterogeneous nucleation at a fibril surface or joining of
an existing fibril end to the body of another fibril. Kineti-
cally, these processes are distinct. Heterogeneous nucleation
will be a source of new fibril ends, whereas annealing of an
existing fibril end to the body of another fibril will act as a
sink by consuming one growth-competent end. Our kineticanalysis is consistent with a model where fibril ends are
depleted rather than created during the aggregation process,
suggesting that the joining of an existing fibril to the body of
another occurs during OVA self-assembly under these
conditions.
The fact that the rate constants for elongation and end-
joining are of similar magnitude suggests that the ends
behave analogously to free-floating monomers. This may
suggest that joining of fibril ends and elongation have
similar activation barriers. Such a result is plausible because
both processes involve protein-protein assembly.
Analysis of OVA fibril growth kinetics at different
temperatures supports this hypothesis (Fig. 6, A–C). Th
T fluorescence during the assembly of OVA at a concen-
tration of 6.0 mg/mL was recorded at six different temper-
atures (50, 55, 60, 65, 70, and 80C). As expected, the fibril
formation process is accelerated at higher temperatures.
Arrhenius plots show that the ratio r ¼ kj/(2kþ) (see Mate-
rials and Methods) remains essentially constant with
temperature (Fig. 6 C), suggesting that end-joining and
elongation have similar activation barriers. This result
can easily be understood by first assuming an Arrhenius-
like form for the relevant rate constants, i.e., kj ¼
Ae(Eyj/RT) and likewise for kþ. Because our experiments
have shown that
dðlnrÞ
dð1=RTÞz0;
it follows then that Eyj z E
y
þ. Conversely, 2kþN*
does display Arrhenius behavior (Fig. 6 B). Because, forBiophysical Journal 108(9) 2300–2311
FIGURE 6 (A) Kinetic traces of Th T binding by
6.0 mg/mL OVA at 50 (black circles), 55 (red tri-
angles), 60 (blue diamonds), 65 (green crosses),
70 (purple squares), and 80C (pink asterisks).
(Symbols) Experimental data; (black solid lines)
fitted curves. (B) Arrhenius plot for the timescaling
factor 2kþN* for 6.0 mg/mL OVA. (C) Arrhenius
plot for the kj/(2kþ) ratio for 6.0 mg/mL OVA.
Clearly the latter does not exhibit typical Arrhenius
behavior, indicating that end-joining and elonga-
tion have similar energy barriers. To see this figure
in color, go online.
2308 Kalapothakis et al.kf << kþ, kj, the value N* can be approximated by (mtotkf/
kj)
1/2, the gradient of the Arrhenius plot is
dðln½2kþNÞ
dð1=RTÞ z E
y
þ 
1
2
Eyf þ
1
2
Eyj ;
where Ey represents activation energies for each process.
The energy barrier obtained from Fig. 6 B is 97.2 kJ/mol.
The similarities of the energy barriers for end-joining and
fibril growth are interesting and may point to these two
processes being mechanistically similar, i.e., that a strong
parallel may exist between monomer addition at a growth
site and the coalescence of two fibril growth sites. Moreover,
because the polymerization rate changes visibly over the
temperature range studied (as evidenced by Fig. 6 A), the
energy barrier ought to be comparable to RT at that temper-
ature range (2.7–3.1 kJ/mol), assuming that these processes
are rate-limited. Thus, by far the major contribution to the
value obtained from Fig. 6 B must originate from the frag-
mentation process. These considerations lead to an estimate
of 191.2–191.8 kJ/mol for Eyf, which is high compared to
RT, a result that is entirely consistent with the initial
assumption that fragmentation is a slow process. The initial
fibrillar mass fraction does not display any trend as a func-
tion of temperature—indeed, the fits allow significant vari-
ation for this parameter, given that it is a small number.
Notably, temperature does affect the initial seed density
with higher temperatures giving rise to a higher initial
seed concentration; thus, whatever the seeding process is,
it is temperature-dependent. Nevertheless, even samples
incubated at 50C do not display a measurable lag phase,
indicating that the initial number of seeds never falls below
the threshold value required for an appreciable lag phase to
be observed. It is worth noting that, while we have fit a
straight line to Fig. 6 B, we cannot rule out that the data ex-
hibits nonlinear, convex Arrhenius behavior. Such complex
temperature dependence has been previously observed in
the kinetics of certain enzyme reactions and has been
ascribed to partial inhibition (loss of reactant species) at
higher temperatures (36). Our data could be consistent
with either the loss of reactants, through denaturation of
seeds or monomeric protein in the conformation suitable
for elongation, or a decrease in the apparently large energy
barrier required for fragmentation. Nonetheless, both theBiophysical Journal 108(9) 2300–2311kinetic data and the temperature dependence taken together
are consistent with fragmentation being slower (and having
a higher energy barrier) than the other processes.The effect of end-joining on self-assembly
dynamics and implications for amyloid-like fibril
growth
Our model of ovalbumin self-assembly establishes a link
between subtle features of the aggregation kinetics and the
molecular processes underlying self-assembly: in this case
the joining between fibril ends. Such processes give rise
to the formation of nano- and microscale structures with
intriguing morphologies (e.g., loops). Such a model can
also be enlisted to interpret a far wider array of self-assem-
bly phenomena. In the limit of a vanishing end-joining term
and a low seed concentration, the kinetics approach the
nucleation, growth, and fragmentation model, which begins
with a lag phase but is followed by fast growth, equilibrating
rapidly due to its autocatalytic nature (8,9). Polymerization
with low initial seed concentration and an end-joining
term that effectively cancels out a small fragmentation
term qualitatively resembles the classical nucleation-and-
growth case, characterized by a short lag phase followed
by a growth phase but with slow equilibration (37). When
the end-joining term is sufficiently high it will effectively
inhibit the polymerization process by removing elongation
sites. By counteracting the effects of fibril fragmentation, in-
clusion of end-joining gives rise to kinetic curves that can
have either abrupt (small end-joining rate constant) or
slow (large end-joining rate constant) equilibration after
the growth phase.
The fibril length distribution at late times resulting
from this case is exponential, a hallmark of polymer
fragmentation (38), but significantly broadened, indicating
that end-joining dynamically stabilizes large aggregates
(see Fig. S3 B). Thus the simple inclusion of an end-joining
term to the equations describing linear polymerization
and fibril breaking can significantly improve the quantitative
understanding of protein fibrillization (and other similar
polymerization reactions) as well as describing processes,
such as those observed for OVA, which cannot be accounted
for without it. For completeness, we compare our model
Kinetic of Ovalbumin Fibril Formation 2309with two recent models that specifically take into account
end-joining (35,39). Yang et al. (39) studied an equilibrium
model for linear and closed-loop formation, deriving rate
equations for monomers (depletion) and the concentration
of an average fibril, which were then solved numerically
using the rate constants inferred from equilibrium measure-
ments. In our work we are not treating the system in equilib-
rium, mainly because it is uncertain whether these systems
ever truly reach equilibrium due to gelation or other mech-
anisms of kinetic arrest. Instead, we fit the kinetics to the
analytical model to obtain rate constants, rather than obtain-
ing them from the equilibrium state. We believe this method
provides a better route in obtaining the various kinetic
parameters of the system. More recently, Michaels and
Knowles (35) studied a kinetic model similar to ours that,
compared to our model, includes several other reactions to
satisfy microscopic reversibility. However, their theoretical
analysis pertains to the aggregation in the absence of pre-
formed seed aggregates, and is thus not directly applicable
to our experiments.
The model described by Eqs. 4 and 5 and its solutions
(Eq. 16 as well as Eqs. S22 and S35 in the Supporting
Material) can be used to reveal whether end-joining and
fragmentation contribute significantly to a fibrillization pro-
cess based on the aggregation kinetics. In doing so, several
new questions are opened up. What are the molecular pro-
cesses that allow end-joining to occur, which may explain
the apparent values of the rate constants? The fact that the
systems under question grow linearly into fibrils implies
that there exists a preferred direction for growth (at least
once a sufficiently large oligomer has already formed); but
can anything be said about the arrangement of the peptides
in the fibril core? In straight amyloid-like fibrils, peptide
strands are thought to exist in a highly ordered, quasi-crys-
talline state (40,41). Such an arrangement limits the number
of orientations in which another fibril end may dock to an
existing end, unless monomers at fibril ends initially
have a different configuration before they adopt that of the
fibril interior. Alternatively, the interface between mono-
mers in a fibril may exhibit some structural heterogeneity,
which might, in turn, explain not only high end-joining
and elongation rates but also the flexibility of the resulting
fibers, observed for OVA and other aggregating proteins
(42–44). Thus, end-joining (and possibly elongation) must
either be a multistepped process (dock-and-lock), or a
certain degree of structural variability should be expected
along the fibril.
The mechanism of loop formation in this work occurs by
virtue of the intrinsic flexibility of these wormlike fibrils.
We have estimated the persistence length of these fibrils
to be 26 nm (Fig. S2). Accordingly, the average angle at
which the tangential direction along the fibril becomes
uncorrelated is ~1 radian. A closed loop of 2p radians
must therefore have a diameter of at least ~150 nm, which
agrees well with the mean length of the fibrils in thisstudy z230 nm (Fig. S3 A). For long straight fibrils with
much higher persistence length (on the order of microns
or greater), the formation of such closed looped morphol-
ogies would be an energetically expensive process. Other
mechanisms then must come into play in order to form
such morphologies, as was recently highlighted by Jordens
et al. (45).
Several proteins form polymorphic fibrils. Some form
different fibril morphologies under different environmental
conditions (such as in apo-C II (46), a-syn (43,44), b-2m
(18), and OVA (47,48)). Alternatively some, like Ab, form
flexible, wormlike fibrils early in the aggregation process
before the appearance of rigid fibrils (9). As with OVA, in
several other cases end-joining is implied by the presence
of loops (21–27). Notably, aggregation leading to the forma-
tion of wormlike fibrils will often either exhibit a short lag
phase, or not exhibit a lag phase at all, indicating that the
process giving rise to the critical concentration of growth-
competent species is rapid: is this situation brought about
by the inherent stability of the nucleus for wormlike fibrils
or is it a result of wormlike fibrils being able to grow
from a heterogeneous mix of monomer conformations?
Another question, of relevance to the role of amyloid-like
fibrils in disease, concerns the toxicity of the fibril popula-
tion resulting from this mechanism (which has also been
raised by Hatters et al. (21)). In the long-time limit,
assuming that the fibrils do not undergo any further rear-
rangements, the fibril length distribution will be broad but
exponential. For flexible fibrils, and even with the inclusion
of fibril fragmentation, small loops will be present from the
initial growth phase onwards (Fig. 5). The consequences of
such a fibril length distribution are determined by which
species are cytotoxic. Shorter fibrils formed by fragmenta-
tion of larger amyloid fibrils have been found to be more
cytotoxic for a number of systems, including a-synuclein
(49). If protein oligomers or short fibrillar aggregates are
the toxic species, loop formation would be desirable
because it would act as a protective sink, locking away the
constituent proteins in an inert state for an extended time.
Loops formed early in the aggregation process will be stable
because they cannot grow any further, and their breaking is
relatively infrequent due to their small length (which limits
the number of possible breakage sites). Thus, a method of
inducing fibril end-joining would delay the accumulation
of toxic species.
Alternatively, it has been proposed that annular morphol-
ogies observed in Ab (1-40) and a-synuclein (22) are remi-
niscent of a class of pore-forming bacterial toxins that can
disrupt cellular membranes (50). If these structures are
indeed toxic, loop formation would result in a long-lived
population of harmful morphological species. More work
needs to be done to characterize the role of circularized mor-
phologies in cellular toxicity. Ultimately, relating fibril
morphology to the growth pathway can contribute to ratio-
nalizing therapeutic strategies for amyloidoses.Biophysical Journal 108(9) 2300–2311
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